Coverage
-
February 17, 2022
The U.S. Department of Health and Human Services disregarded federal law when it sent AstraZeneca a violation letter accusing it of going against a nationwide program mandating discount drug prices for targeted groups, a Delaware federal judge determined.
4 other articles on this case.
View all »